| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4166458 | The Journal of Pediatrics | 2008 | 8 Pages |
Abstract
Reactivation is a frequent and early event in MS-LCH, but involvement of risk organs at reactivation is rare and mortality is minimal. However, reactivations increase the risk for permanent consequences by about 2-fold. Prospective trials targeting reduction of acute morbidity and permanent disabilities through nontoxic treatment of the reactivations are warranted.
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
Milen MD, PhD, Manuel MD, Ulrike PhD, Maurizio MD, Jorge MD, Jean MD, Nicole MD, Jan-Inge MD, PhD, Gritta MD, Kenneth MD, PhD, Sheila MD, Kevin MD, Stephan MD, Helmut MD, FRCP (Glasgow), International LCH Study Group International LCH Study Group,